Inpatient Hospitalizations for COVID ‐19 Among Patients With Prader–Willi Syndrome: A National Inpatient Sample Analysis
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63980 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von James Luccarelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Prader-Willi Syndrome, COVID-19, Hospitalization. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, Foundation for Prader-Willi Research, National Institute of Mental Health.
Abstract (Originalsprache)
Prader–Willi syndrome (PWS) is a genetic disorder associated with baseline respiratory impairment caused by multiple contributing etiologies. While this may be expected to increase the risk of severe COVID‐19 infections in PWS patients, survey studies have suggested paradoxically low disease severity. To better characterize the course of COVID‐19 infection in patients with PWS, this study analyses the outcomes of hospitalizations for COVID‐19 among patients with and without PWS. The National Inpatient Sample, an all‐payors administrative claims database of hospitalizations in the United States, was queried for patients with a coded diagnosis COVID‐19 in 2020 and 2021. Hospitalizations for patients with PWS compared to those for patients without PWS using Augmented Inverse Propensity Weighting (AIPW). There were 295 (95% CI: 228–362) COVID‐19 hospitalizations for individuals with PWS and 4,112,400 (95% CI: 4,051,497–4,173,303) for individuals without PWS. PWS patients had a median age of 33 years compared to 63 for those without PWS. Individuals with PWS had higher baseline rates of obesity (47.5% vs. 28.4%). AIPW models show that PWS diagnosis is associated with increased hospital length of stay by 7.43 days, hospital charges by $80,126, and the odds of mechanical ventilation and in‐hospital death (odds ratios of 1.79 and 1.67, respectively). PWS patients hospitalized with COVID‐19 experienced longer hospital stays, higher charges, and increased risk of mechanical ventilation and death. These results suggest that PWS should be considered a risk factor for severe COVID‐19, warranting continued protective measures and vaccination efforts. Further research is needed to validate coding for PWS and assess the impact of evolving COVID‐19 variants and population immunity on this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Foundation for Prader-Willi Research, Covina, California, USA.
ORCID-Profile: Theresa V Strong
Förderung
- NIMH NIH HHS
- Foundation for Prader-Willi Research
- National Institute of Mental Health
Zitieren
APA
Luccarelli, J., Strong, T. V., Rubin, E. B., & McCoy, T. H. (2025). Inpatient Hospitalizations for COVID ‐19 Among Patients With Prader–Willi Syndrome: A National Inpatient Sample Analysis. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63980
Vancouver
Luccarelli J, Strong TV, Rubin EB, McCoy TH. Inpatient Hospitalizations for COVID ‐19 Among Patients With Prader–Willi Syndrome: A National Inpatient Sample Analysis. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63980
BibTeX
@article{Luccarelli2025,
author = {Luccarelli, James and Strong, Theresa V and Rubin, Emily B and McCoy, Thomas H},
title = {Inpatient Hospitalizations for COVID ‐19 Among Patients With Prader–Willi Syndrome: A National Inpatient Sample Analysis},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63980}
}
EUVIMED